AbbVie and NorthWest EHealth announce partnership to explore autoimmune conditions

Hand shaking to depict AbbVie and NorthWest EHealth partnership

AbbVie, a research-based global biopharmaceutical company, together with NorthWest EHealth, announces their partnership to explore the underlying associations between autoimmune conditions.

The collaboration between AbbVie’s UK business and North West EHealth will harness NorthWest EHealth’s proprietary FARSITE software, a cohort finding tool that utilises primary care data.

The North West is an ideal region for this type of investment due to Greater Manchester’s diverse population and its open approach to collaboration with industry, as reflected by the Memorandum of Understanding between the Association of the British Pharmaceutical Industry and the Greater Manchester Combined Authority. It is a prime example of the collaboration approach recommended by the UK Government’s Life Sciences Industrial Strategy.

Alice Butler, AbbVie UK Medical Director commented: “Harnessing the power of NHS data sets offers a significant opportunity to expand our collective knowledge of disease and ultimately work together to raise standards of care. We hope that the partnership model we have developed with NorthWest EHealth could serve as a best practice exemplar for future industry-NHS collaborations.”

Julie Millar, Head of Community Services, NorthWest EHealth, added: “We are delighted to collaborate with AbbVie. Using our FARSITE tool and expertise in interrogating health records, we hope to provide a valuable contribution to advancing scientific understanding of the associations between autoimmune conditions.”